CAMBRIDGE, MA, USA I May 17, 2025 I Be Biopharma, Inc. (“Be Bio”), a clinical-stage company pioneering the discovery and development of engineered B Cell ...

A landmark review, now published in the Journal of Experimental & Clinical Cancer Research, offers a sweeping and ...

A CRISPR treatment seems to have been effective for a baby’s devastating disease, but it is not clear whether such bespoke ...

The firm announced deals with UMass Chan Medical School and Quiver to further its ambitions to develop transformative treatments for the condition.

A n infant with a life-threatening and incurable genetic disease has become the first human to successfully receive a ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer's ...

Researchers developed a new machine learning method that, given a relevant amino acid sequence, can automatically predict the location of a protein in any human cell line down to the single-cell level ...

Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...

The firm must deprioritize a mitochondrial disease program in order to fast-track PBGENE-DMD to a Phase I study.

QurAlis' FlexASO® platform was developed to generate splice-switching ASOs with improved potency, increased therapeutic index and improved bio-distribution. This bespoke platform has the potential to ...